Press Releases

Dec 16, 2020

Veracyte Announces New Preliminary Data for Its In-Development Lung Cancer Portfolio Tests

Read More

Dec 15, 2020

Veracyte Announces Expansion of Collaboration with the Lung Cancer Initiative at Johnson & Johnson

Read More

Dec 03, 2020

Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020

Read More

Nov 23, 2020

Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference

Read More

Nov 17, 2020

Veracyte Announces New General Manager Structure to Advance Global Expansion

Read More

Nov 05, 2020

Prosigna Breast Cancer Assay Now Approved for Reimbursement in Germany

Read More

Nov 02, 2020

Veracyte Announces Third Quarter 2020 Financial Results

Read More

Oct 30, 2020

Veracyte Announces New Data Published in Journal of Clinical Oncology Suggest the Prosigna Breast Cancer Test’s Genomic Underpinning Drives Prognostic Performance

Read More

Oct 22, 2020

Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing Classifier

Read More

Oct 19, 2020

Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020

Read More